Answer
The safety and efficacy of NuvaRing have been established in women aged 18 to 40 years.
Sources for this answer
- NuvaringOrganon Pharma (UK) Limited · emc · SmPC §4.1 Therapeutic Indications · Version 22Document updated
Sources checked
loading page…
Sources checked